Virginia Retirement Systems Et Al Voyager Therapeutics, Inc. Transaction History

Virginia Retirement Systems Et Al

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.94 - $5.44 $170,208 - $235,008	-43,200 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$4.61 - $9.04 $101,881 - $199,783	22,100 Added 104.74%	43,200 $203,000
Q4 2020 Feb 16, 2021	BUY	$7.15 - $12.28 $27,885 - $47,892	3,900 Added 22.67%	21,100 $151,000
Q3 2020 Nov 12, 2020	BUY	$10.01 - $13.75 $172,172 - $236,500	17,200 New	17,200 $184,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $218M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.